What Does Lodo Therapeutics Corporation Do?

Total employees7
HeadquartersNew York
Founded2015

Lodo Therapeutics Corporation was a drug discovery and development company that specialized in identifying novel therapeutic candidates from microbial natural products found in previously unculturable organisms. Utilizing a proprietary genomics-based platform, Lodo aimed to unlock nature's 'dark matter' to find new medicines for a range of diseases, including challenging infections and cancers. The company was acquired by Zymergen in May 2021, which was subsequently acquired by Ginkgo Bioworks.

Where Is Lodo Therapeutics Corporation's Headquarters?

HQ Function

The New York headquarters served as the central hub for research and development, laboratory operations, corporate strategy, and business administration prior to its acquisition.

Notable Features:

Located in the Alexandria Center for Life Science, a premier urban campus for life science companies, offering state-of-the-art laboratory facilities and fostering a collaborative R&D environment.

Work Culture:

As a research-intensive biotech, Lodo likely fostered a highly innovative, science-driven, and collaborative work culture. Employees were focused on cutting-edge genomic and microbiological research with a mission to discover novel therapeutics.

HQ Significance:

The headquarters' location within a major U.S. biotech hub provided access to top scientific talent, research institutions, potential partners, and investors.

Values Reflected in HQ: The choice of location and facility likely reflected values of innovation, scientific excellence, collaboration, and cutting-edge research.

Location:

Prior to its acquisition, Lodo Therapeutics Corporation's operations were primarily based in the United States. Its research into microbial diversity had global implications, potentially involving sample collection or collaborations on an international scale, but it did not maintain significant physical office presences globally.

Street Address:

430 East 29th Street, 14th Floor

City:

New York

State/Province:

NY

Country:

USA

Where Else Does Lodo Therapeutics Corporation Operate Around the World?

No additional office locations available.

Buying Intent Signals for Lodo Therapeutics Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Lodo Therapeutics Corporation? Meet the Executive Team

As of April 2025, Lodo Therapeutics Corporation' leadership includes:

Dale Pfost, PhD - Former Chairman and Chief Executive Officer
Sean F. Brady, PhD - Co-Founder & Scientific Advisor
David Pompliano, PhD - Former Chief Scientific Officer
Steve Russo - Former Chief Financial Officer

Who's Investing in Lodo Therapeutics Corporation?

Lodo Therapeutics Corporation has been backed by several prominent investors over the years, including:

Arch Venture Partners
AbbVie Ventures
Alexandria Venture Investments
GV (formerly Google Ventures)
The Bill & Melinda Gates Foundation Strategic Investment Fund
Polaris Partners
Johnson & Johnson Innovation - JJDC, Inc.
WRF Capital
Verily Life Sciences (an Alphabet company)
Eli Lilly and Company
The Pfizer Foundation

What Leadership Changes Has Lodo Therapeutics Corporation Seen Recently?

Hire0
Exits0

Lodo Therapeutics Corporation was acquired by Zymergen in May 2021, which was subsequently acquired by Ginkgo Bioworks. Therefore, there have been no executive hires or exits for Lodo Therapeutics as an independent entity in the last 12 months. Leadership transitions occurred as part of these acquisitions.

What Technology (Tech Stack) Is Used byLodo Therapeutics Corporation?

Discover the tools Lodo Therapeutics Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Lodo Therapeutics Corporation Email Formats and Examples

Lodo Therapeutics Corporation likely utilized common corporate email formats. Given its acquisition, emails to @lodotherapeutics.com are unlikely to be active.

[first_initial][last]@lodotherapeutics.com (e.g., jsmith@lodotherapeutics.com) or [first].[last]@lodotherapeutics.com (e.g., john.smith@lodotherapeutics.com)

Format

dphost@lodotherapeutics.com (example based on former CEO)

Example

0%

Success rate

What's the Latest News About Lodo Therapeutics Corporation?

PR Newswire (via Zymergen)May 11, 2021

Zymergen Acquires Lodo Therapeutics to Accelerate and Expand Product Pipeline

Zymergen Inc. announced its acquisition of Lodo Therapeutics Corporation. The acquisition was intended to integrate Lodo's pioneering drug discovery platform with Zymergen's synthetic biology expertise to develop novel products....more

Lodo Therapeutics Press Release / FierceBiotechSeptember 18, 2018

Lodo Therapeutics Secures $17 Million in Series A Financing to Advance Novel Drug Discovery Platform

Lodo Therapeutics announced the completion of a $17 million Series A financing round. The funding was co-led by ARCH Venture Partners and included significant participation from AbbVie Ventures, Alexandria Venture Investments, an affiliate of The Bill & Melinda Gates Foundation, and others, to advance its genomics-based drug discovery platform....more

Lodo Therapeutics Press Release / Business WireJanuary 9, 2017

Lodo Therapeutics Corporation Launches with Investment from AbbVie, Alexandria Venture Investments, ARCH Venture Partners and The Bill & Melinda Gates Foundation

Lodo Therapeutics Corporation officially launched its operations with significant seed investment to develop its platform for discovering novel therapeutics by accessing the vast chemical diversity encoded in microbial DNA....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Lodo Therapeutics Corporation, are just a search away.